Lilly’s diabetes drug matches Victoza
February 26, 2014Research and Development, Sales and Marketing EMA, FDA, Victoza, dulaglutide, lilly
Eli Lilly’s once-weekly diabetes candidate dulaglutide has matched Novo Nordisk’s established once-daily Victoza (liraglutide) when it comes to lowering blood …
FDA: India needs more inspectors
February 25, 2014Manufacturing and Production FDA, India, generics, hamburg
The Food and Drug Administration is to put more inspectors on the ground in India, following a visit there by …
Samsung focussing increasingly on health tech
February 25, 2014Medical Communications, Sales and Marketing Apple, Samsung, digital, health tech, innovation lab, smartwatch
Samsung has partnered with a US university to create a digital health innovation laboratory whilst also unveiling some new health-tracking …
UCB names next chief executive
February 25, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UCB, tellier
Biopharma firm UCB has confirmed its current chief executive Roch Doliveux is to be replaced by Jean-Christophe Tellier. Tellier (pictured) …
NICE restricts Yervoy use
February 25, 2014Sales and Marketing BMS, Cancer, NHS, NICE, Yervoy, melanoma
Bristol-Myers Squibb has been dealt a blow by NICE after the UK cost watchdog recommended that the use of skin …
FDA given $20 million for generic testing
February 24, 2014Manufacturing and Production, Sales and Marketing ADHD, FDA, generics, hamburg
The FDA has been given $20 million to help it assess generic treatments, a group of drugs that makes up …
Europe poised for generic Symbicort
February 24, 2014Manufacturing and Production, Sales and Marketing AstraZeneca, CHMP, COPD, Symbicort, Teva, breo, generics
The CHMP has given Teva Pharmaceutical Industries a lift by recommending that its generic version of AstraZeneca’s lung drug Symbicort …
CHMP breathes new life into GSK, Teva and Novartis
February 24, 2014Research and Development, Sales and Marketing CHMP, COPD, EMA, GSK, Gilead, Teva, asthma, onoro
The CHMP has given its backing to a number of new treatments for respiratory diseases, which include two from London-based …
A treatment room view
February 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDF, Cancer, NHS, NICE, Roche, avastin, hinsely
A little more than a year ago, Lisa Hinsley’s prospects were not good. The mother of three had been diagnosed …
New VP of Operations for Exco InTouch
February 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Exco InTouch, burke
Healthcare data services firm Exco InTouch has appointed Laurence Burke as its vice president of Operations. Burke takes over 20 …
‘Compassionate’ use of hep C combo
February 24, 2014Research and Development, Sales and Marketing CHMP, EMA, Gilead, hep C, ledipasvir, sovaldi
A key adviser to the European regulator has said that Gilead Sciences’ fixed-dose combination of Sovaldi and ledipasvir can be …
New head of Biosimilars for Merck KGaA
February 21, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck KGaA, biosimilars, simon sturge
Simon Sturge is joining Merck KGaA from Boehringer Ingelheim in order to head its Biosimilars unit. In his new role …
GSK/Theravance lung drug bags CHMP approval
February 21, 2014Sales and Marketing CHMP, COPD, GSK, Theravance, anoro
The CHMP has given its backing to GlaxoSmithKline and partner Theravance’s new chronic obstructive pulmonary disease medicine Anoro. The treatment …
Avillion appoints pharma veteran as chief executive
February 21, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allison Jeynes-Ellis, Avillion
Drug development firm Avillion has appointed Dr Allison Jeynes-Ellis to be its chief executive. By stepping into the role Jeynes-Ellis …
Skin cancer pill shows ‘significant’ response
February 20, 2014Research and Development, Sales and Marketing LDE225, Novartis, bolt, skin cancer, smo
Novartis is celebrating after its investigational pill targeting the most common form of skin cancer met its primary endpoint in …
Police raid Novartis Tokyo office
February 20, 2014Medical Communications, Sales and Marketing Diovan, Japan, Novartis, tokyo
Authorities in Japan have raided the premises of Novartis’ Tokyo operation as part of an ongoing investigation into the promotion …
Apple files healthcare tech headphones
February 20, 2014Medical Communications, Sales and Marketing Apple, Samsung, iwatch, technology, wearable
A recently-published Apple patent has shed light on a new health-monitoring device that will be built into a pair of …
RSA appoints director of Information
February 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Claes Zackrisson, rsa
Life sciences executive search and interim management firm RSA has appointed Claes Zackrisson as its first director of information. Zackrisson …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
